Pro- and anti-inflammatory cytokines are significantly decreased at acute time points following IR. حسب Jordan A. Gunning (18143970)

Mean ± SD values of unipedal stance parameters evaluated at the different time points of the postural training session. حسب Cristina Dolciotti (16317330)

List of significant association rules. حسب Mahmoud Alfadel (8721360)

DHA decreased cell viability in HepG3 cells. حسب Arlet Hernandez (12289155)

Depletion of putative SDH subunits leads to decreased SDH activity and oxygen consumption. حسب Mariana F. Silva (10219520)

Mean and standard error of the mean for force capability according to anchor point level change. حسب Jihun Kim (10091)

الموضوعات:

Homozygous deletion of <i>ERG251</i> leads to the decreased ergosterol accumulation in the absence of FLC and decreased production of toxic dienol in the presence of FLC. حسب Xin Zhou (54275)

Middle cerebral artery mean flow velocity at three time points. حسب Marco Carbonara (11483575)

الموضوعات:

The mean and standard deviation of parameters. حسب Sadaf Sepasgozar Sarkhosh (20436143)

الموضوعات:

Rule-based prompting. حسب Talya Natanya (22574382)

Spatial information is significantly decreased in dCA1 and vCA1 in APP/PS1 mice. حسب Udaysankar Chockanathan (18510288)

"…(B) In dCA1, spatial information was decreased in APP/PS1 mice relative to C57BL/6 controls (mean ± std: C57BL/6 = 0.132 ± 0.048, APP/PS1 = 0.128 ± 0.051, p < 0.005, two-sided Wilcoxon rank-sum test, n_C57BL/6 = 305 units from 5 recording sessions, n_APP/PS1 = 180 units from 4 recording sessions). …"

Task variability/correlations decrease independently of mean task activity removal step in fMRI data. حسب Takuya Ito (57473)

HRV parameters at different time points. حسب Shiying Liu (1569478)

الموضوعات:

PAP I point mutations lead to a decrease in pYV PCN, plasmid stability, and T3SS activity. حسب Katherine Schubert (5452712)

Divergence from transmitted/founder (TF) virus increases during ART-naïve infection and decreases on treatment. حسب Kelsie Brooks (8928044)

Summary of post-treatment disease course measures from MDMA-AT publications. حسب Filip Stanicic (17808254)

الموضوعات:

Study selection criteria. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. حسب Filip Stanicic (17808254)

الموضوعات:

Disease course measures after the PTSD treatments. حسب Filip Stanicic (17808254)

الموضوعات:

PICOS criteria for the SLR. حسب Filip Stanicic (17808254)

الموضوعات: